September 2, 2021
Dear Advocate,
AVAC is now inviting applications for its
2022 Advocacy Fellows Program. Read on for more about the program, what’s new in 2022, application details and upcoming informational calls.
DOWNLOAD APPLICATION MATERIALS HERE.
The application deadline is October 12, 2021.
AVAC’s Advocacy Fellows Program aims to expand and strengthen the capacity of civil society advocates and organizations to monitor, support and help shape HIV prevention research and rapid rollout of new effective interventions in low- and middle-income countries with high HIV burdens. At AVAC, we believe the most effective and sustainable advocacy integrates the interests and priorities of individuals and organizations, and prioritizes resilient partnerships. The Fellows program is guided by these principles.
Projects address locally identified gaps and priorities. Fellows receive training, full-time financial support and technical assistance to plan and implement a targeted 18-month project within host organizations working in HIV or related advocacy. Host organizations are critical partners in the program. Fellows’ projects can be an opportunity for an organization to further develop its own work in HIV prevention advocacy.
Since launching in 2009,
77 Fellows and 67 partner organizations from 14 countries have participated in the program. They have gone on to change policy, champion community perspectives, help strengthen healthcare systems, demystify HIV prevention research, and insist on fairness and transparency locally, regionally and globally.
Read more about the work and achievements of past Fellows.
What's New for the 2022 Program
The 2022 program reflects an intensive
independent review of the program’s impact and contribution over the last decade. Responding to the recommendations from current and alumni Fellows and Hosts, AVAC is expanding the role of alumni support to Fellows in their countries; strengthening partnerships and capacity building with Host organizations; increasing support to Fellows in countries that do not have alumni networks; expanding training to prepare for post-Fellowship transitions; and increasing the Fellowship length to 18 months.
While HIV biomedical prevention advocacy will continue to be the focus, we encourage a strong focus on health equity, structural issues and linkages to COVID-19 and TB prevention efforts.
Priority will be given to applications from Eastern and Southern Africa where biomedical HIV prevention research is
planned or ongoing or where there is an urgent need for the delivery or scale-up of proven biomedical interventions. To see where HIV research and rollout is being conducted, visit the
Prevention & Research database and the
Trial Map.
HIV Prevention Research Advocacy Fellows are: